Wake Forest Baptist Health will be joining the Alliance clinical trial A021806. This phase III that compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery. Giving chemotherapy before and after surgery may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery.
To learn more about this study: Alliance A021806
To learn more about clinical trials at Wake Forest Baptist Health: Be Involved — Clinical Trials at WFBH
Alliance A021806: A phase III trial of perioperative versus adjuvant chemotherapy for resectable pancreatic cancer